Gupta G, Joshi D, Narayan G, Sharma S
In Silico Pharmacol. 2025; 13(1):37.
PMID: 40061632
PMC: 11885716.
DOI: 10.1007/s40203-025-00330-8.
Ahammed S, Chowdhury R, Al Hasan M, Mia E, Akbor M, Islam M
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40055204
DOI: 10.1007/s00210-025-03984-5.
Bhambri S, Jha P
Mol Divers. 2025; .
PMID: 39847188
DOI: 10.1007/s11030-025-11107-8.
El-Tanani M, Rabbani S, El-Tanani Y, Matalka I, Khalil I
Heliyon. 2025; 11(1):e41317.
PMID: 39811269
PMC: 11730937.
DOI: 10.1016/j.heliyon.2024.e41317.
Bodun D, Omoboyowa D, Olofinlade V, Ayodeji A, Mauri A, Ogbodo U
In Silico Pharmacol. 2025; 13(1):9.
PMID: 39780769
PMC: 11703796.
DOI: 10.1007/s40203-024-00300-6.
Machine learning assisted classification RASAR modeling for the nephrotoxicity potential of a curated set of orally active drugs.
Banerjee A, Roy K
Sci Rep. 2025; 15(1):808.
PMID: 39755865
PMC: 11700179.
DOI: 10.1038/s41598-024-85063-y.
Exploring purine analogues as inhibitors against Katanin, a microtubule severing enzyme using molecular modeling approach.
Saxena V, Patil P, Khodke P, Kumbhar B
Sci Rep. 2024; 14(1):32095.
PMID: 39738711
PMC: 11686324.
DOI: 10.1038/s41598-024-83723-7.
Indian Medicinal Plant-Derived Phytochemicals as Potential Antidotes for Snakebite: A Pharmacoinformatic Study of Atrolysin Inhibitors.
Ravi D, Hwang D, Prakash R, Kang C, Kim E
Int J Mol Sci. 2024; 25(23).
PMID: 39684388
PMC: 11641534.
DOI: 10.3390/ijms252312675.
Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies.
Pappalardo M, Sipala F, Nicolosi M, Guccione S, Ronsisvalle S
Molecules. 2024; 29(22).
PMID: 39598735
PMC: 11596970.
DOI: 10.3390/molecules29225349.
Computer-Aided Discovery of Compounds With Anti-Schistosomal Potential.
Shoko R, Mazadza A
Biomed Eng Comput Biol. 2024; 15:11795972241294112.
PMID: 39530083
PMC: 11552047.
DOI: 10.1177/11795972241294112.
Novel benzimidazole-based azine derivatives as potent urease inhibitors: synthesis, and approach.
Hamidullah , Alam A, Elhenawy A, Ali M, Latif A, Khan A
Future Med Chem. 2024; 16(22):2337-2350.
PMID: 39311079
PMC: 11622760.
DOI: 10.1080/17568919.2024.2401311.
In Silico Screening of Therapeutic Targets as a Tool to Optimize the Development of Drugs and Nutraceuticals in the Treatment of Diabetes : A Systematic Review.
Gomes A, de Medeiros W, Medeiros I, Piuvezam G, da Silva-Maia J, Bezerra I
Int J Mol Sci. 2024; 25(17).
PMID: 39273161
PMC: 11394750.
DOI: 10.3390/ijms25179213.
Antibacterial and Antioxidant Activities, Pharmacokinetics, and Molecular Docking Study of Phytochemicals from the Roots of .
Gebrehiwot H, Ensermu U, Dekebo A, Endale M, Nefo Duke T
Biochem Res Int. 2024; 2024:7551813.
PMID: 39263680
PMC: 11390196.
DOI: 10.1155/2024/7551813.
The application of chemical similarity measures in an unconventional modeling framework c-RASAR along with dimensionality reduction techniques to a representative hepatotoxicity dataset.
Banerjee A, Roy K
Sci Rep. 2024; 14(1):20812.
PMID: 39242880
PMC: 11379871.
DOI: 10.1038/s41598-024-71892-4.
Biosimilars in the Era of Artificial Intelligence-International Regulations and the Use in Oncological Treatments.
Bas T, Duarte V
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065775
PMC: 11279612.
DOI: 10.3390/ph17070925.
Target Enzymes of and Essential Oils in Black Cutworm (): In Vitro and In Silico Studies.
Ahmed F, Helmy W, Alfuhaid N, Moustafa M
Insects. 2024; 15(7).
PMID: 39057216
PMC: 11276864.
DOI: 10.3390/insects15070483.
Anti-inflammatory effects of thymol: an emphasis on the molecular interactions through approach and molecular dynamic simulations.
Islam M, Bappi M, Bhuia M, Ansari S, Ansari I, Shill M
Front Chem. 2024; 12:1376783.
PMID: 38983677
PMC: 11231963.
DOI: 10.3389/fchem.2024.1376783.
A Physiologically Based Pharmacokinetic (PBPK) Study to Assess the Adjuvanticity of Three Peptides in an Oral Vaccine.
Saldanha L, Langel U, Vale N
Pharmaceutics. 2024; 16(6).
PMID: 38931901
PMC: 11207434.
DOI: 10.3390/pharmaceutics16060780.
Quercetin and Kaempferol as Multi-Targeting Antidiabetic Agents against Mouse Model of Chemically Induced Type 2 Diabetes.
Ali M, Hassan M, Ansari S, Alkahtani H, Al-Rasheed L, Ansari S
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931424
PMC: 11206732.
DOI: 10.3390/ph17060757.
Exploring the Antibacterial Potential of Compounds Targeting the Hydrolase/Antibiotic Protein in : In Vitro and In Silico Investigations.
Alshammari F
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931335
PMC: 11207000.
DOI: 10.3390/ph17060667.
